Clinton Group’s bluebird bio BLUE Stock Holding History

Clinton Group’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-175	Closed	-$383K	–	676
2015 Q2	$383K	Buy	+175	New	+$357K	0.05%	421

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Clinton Group's BLUE Position: Q3 2015 in Review

Clinton Group sold out of bluebird bio (BLUE) in Q3 2015, closing a stake of 175 shares — an estimated $383K sold.

Clinton Group first reported a position in BLUE in Q2 2015 and held it in 1 quarter. The position peaked at $383K in Q2 2015. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.

Clinton Group reported no remaining bluebird bio position as of Q3 2015 after selling out during the quarter.
Clinton Group sold 175 bluebird bio shares in Q3 2015, an estimated $383K.
Clinton Group first reported a position in bluebird bio in Q2 2015 and held it in 1 quarter.
Clinton Group's bluebird bio position peaked at $383K in Q2 2015.
192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.

Based on Clinton Group's 13F filing for Q3 2015, filed 13 Nov 2015.